Canada TLS Core
Natural health product licensed in Canada
- Licence holder
- Market America Inc.
- NPN or DIN-HM
- 80128395
- Status
- Active licence
- Licence date
- 5 December 2023
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Aphanizomenon flos-aquae Ralfs ex Bornet & Flahault: Les préparations de cette plante sont seulement autorisées s'il peut être démontré par des rapports d'analyse qu'elles ne contiennent pas de microcystine (< 1µg/g) et d'autres toxines marines.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Aphanizomenon flos-aquae Source : aphanizomenon flos-aquae - whole | 17.75 mg | Not calculated |
| Punica granatum Source : Punica granatum - Graine Potency : 40 % Ellagic acid | 3.5 mg | Not calculated |
| Phaseolus vulgaris Source : Phaseolus vulgaris - Graine Potency : 2,670 Unités d'Inhibition de l'Alpha-Amylase Alpha-Amylase Inhibitors | 222.5 mg | Not calculated |
| Phaseolus vulgaris Source : Phaseolus vulgaris - Graine | Not specified | Not calculated |
| Cyamopsis tetragonoloba Source : Fève | 36.375 mg | Not calculated |
| Ceratonia siliqua | 24.25 mg | Not calculated |
| bêta-Carotène Source : bêta-carotène | 7.5 mg | Not calculated |
Non-medicinal ingredients
Poly(éthylène glycol), Amidon de pois, Hydroxypropylcellulose, Dioxyde de silicium, Croscarmellose de sodium, Stéarate de magnésium, Maltodextrine, Hypromellose, Cellulose microcristalline, Acide stéarique, Eau, Alginate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain/support normal blood glucose levels. Helps to maintain/support the body's ability to metabolize nutrients. Helps to prevent chromium deficiency. Provides support for healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80128395
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.